These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 15506428)

  • 41. Effects of BAY 41-2272, an activator of nitric oxide-independent site of soluble guanylate cyclase, on human NADPH oxidase system from THP-1 cells.
    Borges de Oliveira-Junior E; Thomazzi SM; Rehder J; Antunes E; Condino-Neto A
    Eur J Pharmacol; 2007 Jul; 567(1-2):43-9. PubMed ID: 17499238
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nitric oxide signaling modulates synaptic transmission during early postnatal development.
    Cserép C; Szonyi A; Veres JM; Németh B; Szabadits E; de Vente J; Hájos N; Freund TF; Nyiri G
    Cereb Cortex; 2011 Sep; 21(9):2065-74. PubMed ID: 21282319
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Regulation of cytosolic guanylyl cyclase by nitric oxide: the NO-cyclic GMP signal transduction system.
    Murad F
    Adv Pharmacol; 1994; 26():19-33. PubMed ID: 7913616
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Nitric oxide modulates striatal neuronal activity via soluble guanylyl cyclase: an in vivo microiontophoretic study in rats.
    Di Giovanni G; Ferraro G; Sardo P; Galati S; Esposito E; La Grutta V
    Synapse; 2003 May; 48(2):100-7. PubMed ID: 12619044
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Measurement of cGMP and soluble guanylyl cyclase activity.
    Southam E
    Curr Protoc Toxicol; 2001 May; Chapter 10():Unit 10.5. PubMed ID: 23045027
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cerebellar localization of the NO-receptive soluble guanylyl cyclase subunits-alpha(2)/beta (1) in non-human primates.
    Bidmon HJ; Mohlberg H; Habermann G; Buse E; Zilles K; Behrends S
    Cell Tissue Res; 2006 Dec; 326(3):707-14. PubMed ID: 16819625
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Migrating neuroblasts of the rostral migratory stream are putative targets for the action of nitric oxide.
    Gutièrrez-Mecinas M; Crespo C; Blasco-Ibáñez JM; Nácher J; Varea E; Martínez-Guijarro FJ
    Eur J Neurosci; 2007 Jul; 26(2):392-402. PubMed ID: 17623019
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Receptor-controlled phosphorylation of alpha 1 soluble guanylyl cyclase enhances nitric oxide-dependent cyclic guanosine 5'-monophosphate production in pituitary cells.
    Kostic TS; Andric SA; Stojilkovic SS
    Mol Endocrinol; 2004 Feb; 18(2):458-70. PubMed ID: 14630997
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Distribution of soluble guanylyl cyclase in the rat brain.
    Ding JD; Burette A; Nedvetsky PI; Schmidt HH; Weinberg RJ
    J Comp Neurol; 2004 May; 472(4):437-48. PubMed ID: 15065118
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Autoregulation of nitric oxide-soluble guanylate cyclase-cyclic GMP signalling in mouse thoracic aorta.
    Hussain MB; Hobbs AJ; MacAllister RJ
    Br J Pharmacol; 1999 Nov; 128(5):1082-8. PubMed ID: 10556946
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Differential expression of NO-sensitive guanylyl cyclase subunits during the development of rat cerebellar granule cells: regulation via N-methyl-D-aspartate receptors.
    Jurado S; Sanchez-Prieto J; Torres M
    J Cell Sci; 2003 Aug; 116(Pt 15):3165-75. PubMed ID: 12799420
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of nitric oxide on the cyclic guanosine monophosphate (cGMP) pathway during meiosis resumption in bovine oocytes.
    Schwarz KR; Pires PR; Mesquita LG; Chiaratti MR; Leal CL
    Theriogenology; 2014 Mar; 81(4):556-64. PubMed ID: 24331454
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The inhibitory effect of sodium nitroprusside on HIF-1 activation is not dependent on nitric oxide-soluble guanylyl cyclase pathway.
    Takabuchi S; Hirota K; Nishi K; Oda S; Oda T; Shingu K; Takabayashi A; Adachi T; Semenza GL; Fukuda K
    Biochem Biophys Res Commun; 2004 Nov; 324(1):417-23. PubMed ID: 15465035
    [TBL] [Abstract][Full Text] [Related]  

  • 54. On the activation of soluble guanylyl cyclase by nitric oxide.
    Bellamy TC; Wood J; Garthwaite J
    Proc Natl Acad Sci U S A; 2002 Jan; 99(1):507-10. PubMed ID: 11752394
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Vascular natriuretic peptide receptor-linked particulate guanylate cyclases are modulated by nitric oxide-cyclic GMP signalling.
    Madhani M; Scotland RS; MacAllister RJ; Hobbs AJ
    Br J Pharmacol; 2003 Aug; 139(7):1289-96. PubMed ID: 12890708
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Dual actions of dephostatin on the nitric oxide/cGMP-signalling pathway in porcine iliac arteries.
    Persson AA; Gunnarsson P; Lindström E; Grenegård M
    Eur J Pharmacol; 2005 Oct; 521(1-3):124-32. PubMed ID: 16182278
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Editorial comment to "Cyclic guanosine monophosphate-enhancing reduces androgenic extracellular regulated protein kinases-phosphorylation/Rho kinase II-activation in benign prostate hyperplasia".
    Hennenberg M
    Int J Urol; 2014 Jan; 21(1):92-3. PubMed ID: 23710565
    [No Abstract]   [Full Text] [Related]  

  • 58. Role of nitric oxide/cyclic GMP in myocardial adenosine A1 receptor-inotropic response.
    Sterin-Borda L; Gómez RM; Borda E
    Br J Pharmacol; 2002 Jan; 135(2):444-50. PubMed ID: 11815380
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Praliciguat and Soluble Guanylate Cyclase Stimulators for Peripheral Artery Disease.
    Kosmac K; Ismaeel A; Kim-Shapiro DB; McDermott MM
    Circ Res; 2023 Jan; 132(1):49-51. PubMed ID: 36603062
    [No Abstract]   [Full Text] [Related]  

  • 60. Nitric oxide and cGMP signaling.
    McDonald LJ; Murad F
    Adv Pharmacol; 1995; 34():263-75. PubMed ID: 8562439
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.